Fibrocytes and Fibrovascular Membrane Formation in Proliferative Diabetic Retinopathy

Kazunori Tamaki1, Ayumi Usui-Ouchi1, Akira Murakami2

  • 1Department of Ophthalmology, Juntendo University Urayasu Hospital, Chiba, Japan.

Abstract

Insights

Fibrocytes, a type of immune cell, were found in higher numbers in patients with proliferative diabetic retinopathy (PDR). These cells may play a role in the formation of the fibrovascular membrane (FVM) in PDR.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Proliferative diabetic retinopathy (PDR) is a severe complication of diabetes mellitus.
  • The formation of fibrovascular membranes (FVM) is a hallmark of PDR, leading to vision loss.
  • The cellular origins of FVM in PDR remain incompletely understood.

Purpose of the Study:

  • To investigate the presence and role of fibrocytes in the development of FVM in patients with PDR.
  • To compare the number of fibrocytes in PDR patients with control subjects.
  • To analyze the correlation between fibrocytes and specific inflammatory markers in the vitreous fluid of PDR patients.

Main Methods:

  • Vitreous fluid and FVM samples were collected from PDR patients and controls during vitrectomy.
  • Immunohistochemical analysis was performed on tissue samples.
  • Cells isolated from vitreous fluid were cultured and analyzed for fibrocyte markers.
  • Enzyme-linked immunosorbent assays (ELISA) were used to quantify MCP-1, pentraxin3, and SAP levels in vitreous fluid.

Main Results:

  • Fibrocytes were identified in vitreous and FVM samples from PDR patients.
  • The number of fibrocytes was significantly higher in PDR patients compared to controls.
  • Vitreous fluid from PDR patients showed elevated levels of MCP-1, pentraxin3, and SAP.
  • MCP-1 concentration positively correlated with the number of fibrocytes in the vitreous.

Conclusions:

  • Fibrocytes are present in the fibrovascular membranes of PDR patients.
  • The increased presence of fibrocytes and associated inflammatory markers suggests their involvement in FVM formation.
  • These findings highlight fibrocytes as potential therapeutic targets for PDR.